Starcoin Group Balance Sheet Health
Financial Health criteria checks 0/6
Starcoin Group has a total shareholder equity of HK$25.3M and total debt of HK$1.0B, which brings its debt-to-equity ratio to 4140.5%. Its total assets and total liabilities are HK$1.1B and HK$1.1B respectively.
Key information
4,140.48%
Debt to equity ratio
HK$1.05b
Debt
| Interest coverage ratio | n/a |
| Cash | HK$3.70m |
| Equity | HK$25.34m |
| Total liabilities | HK$1.06b |
| Total assets | HK$1.09b |
Recent financial health updates
Innovative Pharmaceutical Biotech (HKG:399) Has Debt But No Earnings; Should You Worry?
Aug 12
Is Innovative Pharmaceutical Biotech (HKG:399) Using Too Much Debt?
Feb 18Recent updates
We Believe That Innovative Pharmaceutical Biotech's (HKG:399) Weak Earnings Are A Good Indicator Of Underlying Profitability
Jan 03Innovative Pharmaceutical Biotech (HKG:399) Has Debt But No Earnings; Should You Worry?
Aug 12Robust Earnings May Not Tell The Whole Story For Innovative Pharmaceutical Biotech (HKG:399)
Jan 05Is Innovative Pharmaceutical Biotech (HKG:399) Using Too Much Debt?
Feb 18Innovative Pharmaceutical Biotech's(HKG:399) Share Price Is Down 80% Over The Past Five Years.
Nov 26
Financial Position Analysis
Short Term Liabilities: 399's short term assets (HK$8.9M) do not cover its short term liabilities (HK$972.1M).
Long Term Liabilities: 399's short term assets (HK$8.9M) do not cover its long term liabilities (HK$87.7M).
Debt to Equity History and Analysis
Debt Level: 399's net debt to equity ratio (4125.9%) is considered high.
Reducing Debt: 399's debt to equity ratio has increased from 146.6% to 4140.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 399 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 399 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/07 21:53 |
| End of Day Share Price | 2025/11/07 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Starcoin Group Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.